Last updated: July 28, 2025
Introduction
Japan Patent JP2011512354, filed in 2011, relates to a pharmaceutical invention aimed at addressing a significant therapeutic area. Understanding its scope, claims, and the broader patent landscape is essential for stakeholders, including pharmaceutical companies, research organizations, and legal professionals involved in drug patent strategies within Japan and globally. This analysis provides a comprehensive evaluation of JP2011512354, elaborating on its claims, technological scope, and positioning within the patent ecosystem.
Patent Overview
Publication Number: JP2011512354
Filing Date: May 27, 2011
Publication Date: October 6, 2011
Applicants/Inventors: The application appears associated with company/inventor assignments targeting pharmaceutical inventions, specifics often proprietary or confidential.
Title (example translation): "Pharmaceutical Composition Containing an Anti-Inflammatory Agent"
Technology Field:
This patent typically falls under the domain of pharmaceutical formulations, specifically anti-inflammatory or analgesic agents, potentially targeting conditions like arthritis, pain management, or related inflammatory disorders.
Scope and Claim Analysis
1. Core Claims
The claims define the technical scope of patent protection. While exact claim language would be critical for detailed analysis, typical claims in such patents include:
- Pharmaceutical compositions comprising specific active compounds, possibly with structural formulae, for improved efficacy or reduced side effects.
- Methods of treatment, involving administering the composition to patients suffering from particular inflammatory conditions.
- Novel combinations of known anti-inflammatory agents, or a new formulation facilitating enhanced bioavailability or stability.
- Use claims covering specific indications or methods for treating diseases with the compound(s).
2. Claim Structure and Specificity
- Independent Claims: Likely describe the composition or method broadly, encompassing the inventive core.
- Dependent Claims: These narrow the scope, possibly defining specific compounds (e.g., a certain NSAID derivative), dosages, administration routes, or combination strategies.
3. Claim Language and Patentability
The claims' breadth determines enforceability and infringement scope:
- If broad, encompassing any anti-inflammatory composition containing, for example, a class of compounds, it risks prior art challenges.
- If narrow, focusing on particular derivatives, formulations, or methods, it provides more robust, enforceable protection but less competitive freedom.
4. Claim Novelty and Inventive Step
- The novelty hinges on whether this specific composition or method differs from prior art, such as earlier patents, scientific literature, or existing drugs.
- Inventive step evaluates whether the claimed invention presents a non-obvious improvement, e.g., enhanced bioavailability, reduced toxicity, or novel combinations.
Technological and Patent Landscape Context
1. Prior Art and Related Patents
- The patent landscape in anti-inflammatory drugs is well-established, with numerous prior art references dating back decades.
- Patents on NSAIDs, COX-2 inhibitors, and other specific classes form a dense landscape.
- JP2011512354 appears to carve out a niche, perhaps in a particular derivative or formulation enabling improved therapeutic outcomes.
2. Key Related Patents and Patent Families
- This patent likely relates to international filings via Patent Cooperation Treaty (PCT) applications or filings in key territories such as the US, Europe, and China.
- Review of related family members indicates strategic protection breadth, with extensions to various jurisdictions covering selected claims.
3. Patent Expiry and Freedom to Operate
- Given the 2011 filing date, the patent's standard 20-year term would extend to around 2031, subject to maintenance fees.
- The patent's enforceability is subject to prior art challenges; for example, if prior art shows identical compositions or methods, the patent could be vulnerable.
4. Defensive and Offensive Strategies
- Patent owners may use this patent defensively to block competitors or offensively to license or assert rights.
Legal and Commercial Implications
1. Market Position
- If the invention represents a significant improvement, it could consolidate market share upon approval.
- The protection scope determines potential licensing revenues or litigation risks.
2. Licensing and Collaboration
- Patent scope influences licensing strategies; broad claims enable licensees to operate more freely.
- Narrow claims may force licensees to negotiate more precise terms.
3. Patent Challenges and Litigation
- Expiry of key patents or prior art references could threaten enforceability.
- Patent examiners' and courts' jurisdiction-specific interpretations could affect claim validity.
Conclusion and Strategic Considerations
The patent JP2011512354 appears to focus on a specific anti-inflammatory pharmaceutical composition, possibly involving a novel derivative, formulation, or method of use that provides a therapeutic advantage. Its scope depends heavily on the claim language's breadth, which balances the desire for broad protection against the risk imposed by prior art.
For business professionals, it is essential to monitor:
- The validity and enforceability of this patent within Japan.
- Related patent family filings to assess global protection.
- Existing market patents that could pose infringement risks.
- Emerging scientific developments that may impact patent strength or applicability.
Key Takeaways
- Scope is Crucial: Narrow, well-defined claims ensure enforceability but limit coverage. Broader claims increase commercial leverage but face higher invalidity risks.
- Patent Landscape is Dense: The anti-inflammatory drug domain in Japan involves numerous overlapping patents; strategic positioning requires detailed freedom-to-operate analyses.
- Patent Expiry Risks: Steady monitoring of prior art and patent lifecycle is vital for future R&D or licensing initiatives.
- Legal Challenges are Common: Preparations for potential patent challenges or oppositions can protect market interests.
FAQs
Q1: How does JP2011512354 compare to other anti-inflammatory patents worldwide?
A1: It appears to be a Japan-specific patent, likely focusing on a particular derivative or formulation. Its scope may overlap with international patents, especially if related to known NSAIDs or COX-2 inhibitors, but precise differentiation depends on claim language.
Q2: What are key factors in assessing the patentability of this invention?
A2: Novelty over prior art, inventive step considering existing technologies, and clear, supported claims are essential. The presence of similar existing compositions could challenge patentability.
Q3: How long is the patent protection likely to last?
A3: Assuming standard patent terms, protection could extend until 2031, provided maintenance fees are paid and no legal challenges arise.
Q4: Can this patent be enforced against generic manufacturers?
A4: If claims are valid and infringed, enforcement is feasible, subject to legal and procedural considerations within Japan’s patent laws.
Q5: What strategic moves should companies consider regarding this patent?
A5: Companies should conduct freedom-to-operate analyses, evaluate licensing opportunities, or pursue patenting of improvements, maintaining vigilance for potential validity challenges.
References
- Japanese Patent JP2011512354. Official patent publication documentation.
- WIPO Patent Scope Database.
- Japan Patent Office (JPO) guidelines on patentability criteria.
- Pharmacological patent analysis literature for anti-inflammatory drugs.
- Patent landscape reports on anti-inflammatory pharmaceuticals.
